KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biogen (BIIB) Change in Inventory (2016 - 2025)

Historic Change in Inventory for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $29.4 million.

  • Biogen's Change in Inventory fell 5572.29% to $29.4 million in Q4 2025 from the same period last year, while for Dec 2025 it was $64.7 million, marking a year-over-year decrease of 7636.96%. This contributed to the annual value of $64.7 million for FY2025, which is 7636.96% down from last year.
  • Latest data reveals that Biogen reported Change in Inventory of $29.4 million as of Q4 2025, which was down 5572.29% from $7.4 million recorded in Q3 2025.
  • Biogen's Change in Inventory's 5-year high stood at $142.6 million during Q1 2022, with a 5-year trough of -$62.0 million in Q1 2025.
  • Its 5-year average for Change in Inventory is $62.6 million, with a median of $85.6 million in 2021.
  • In the last 5 years, Biogen's Change in Inventory surged by 63038.67% in 2023 and then crashed by 17979.41% in 2025.
  • Quarter analysis of 5 years shows Biogen's Change in Inventory stood at $139.8 million in 2021, then tumbled by 112.95% to -$18.1 million in 2022, then surged by 630.39% to $96.0 million in 2023, then tumbled by 30.83% to $66.4 million in 2024, then crashed by 55.72% to $29.4 million in 2025.
  • Its Change in Inventory was $29.4 million in Q4 2025, compared to $7.4 million in Q3 2025 and $89.9 million in Q2 2025.